Elsevier

Atherosclerosis

Volume 330, August 2021, Pages 107-113
Atherosclerosis

Detailed association between serum uric acid levels and the incidence of chronic kidney disease stratified by sex in middle-aged adults

https://doi.org/10.1016/j.atherosclerosis.2021.06.908Get rights and content

Highlights

  • The association of serum uric acid (SUA) levels with the increase in the risk of chronic kidney disease (CKD) incidence differed by sex.

  • The range of SUA levels associated with an increase in the risk of CKD incidence varied by sex.

Abstract

Background and aims

Chronic kidney disease (CKD) is a global health burden. Previous studies have shown a J- or U-shaped association between serum uric acid (SUA) and cardiovascular mortality. We assessed the risk of CKD incidence in a refined SUA category in middle-aged adults stratified by sex.

Methods

We analyzed data from 138,511 participants <65 years old (29.6% women; mean age 44.1 years) without CKD at baseline acquired from the JMDC database. The Cox model was used to assess the adjusted hazard ratio (HR).

Results

During the mean follow-up period of 4.68 years, 12,589 participants developed CKD. The fully adjusted HRs (95% confidence interval [CI], p-value) for CKD incidence in men with SUA <4.0, 10.0–10.9 and ≥ 11.0 mg/dL compared to men with SUA 4.0–4.9 mg/dL were 1.13 (1.01–1.26, p = 0.030), 1.98 (1.32–2.97, p = 0.0010), and 3.74 (1.68–8.35, p = 0.0013), respectively. The fully adjusted HRs for CKD incidence in women with SUA <4.0, 8.0–8.9, and ≥9.0 mg/dL compared to women with SUA 4.0–4.9 mg/dL were 1.08 (1.01–1.16, p = 0.032), 2.39 (1.07–5.35, p = 0.034), and 3.20 (0.80–12.8, p = 0.10), respectively.

Conclusions

Both high and low SUA levels were identified as risk factors for CKD incidence in middle-aged men and women. The association of SUA levels with the increase in the risk of CKD incidence differed by sex, and the range of SUA levels associated with an increase in the risk of CKD incidence varied by sex.

Introduction

Chronic kidney disease (CKD) is a major global health burden. Globally, CKD incidence, and disability and death due to CKD have been increasing [1]. According to previous studies, serum uric acid (SUA) levels have shown a J- or U-shaped association with all-cause and cardiovascular mortality [2,3].

With regard to the association of SUA with the kidney, high SUA levels may serve as an independent risk factor for CKD [[4], [5], [6], [7], [8], [9], [10], [11]]. Although high SUA levels may be involved in CKD incidence in middle-aged individuals, there is little evidence regarding the association between SUA and CKD incidence in this population. Some studies have indicated a possible association between SUA levels and CKD risk in cohorts with a mean age between 40 and 50 years. Participants in these cohort studies were categorized broadly according to their SUA levels and the CKD risk of the group with SUA ≥7 mg/dL was not clear [7,9,10]. Moreover, in these studies, the CKD incidence was defined using only the eGFR (estimated glomerular filtration rate) levels. Nonetheless, in the Hisayama study, based on 2059 participants, which investigated the influence of SUA levels on the incidence of kidney dysfunction and albuminuria in the general Japanese population, the mean age was 59 years [4]. Precise evidence regarding the association between high SUA levels and CKD risk can contribute to early CKD prevention in middle-aged individuals.

Sex and baseline eGFR can also be strong confounding factors for the association between SUA and the risk of CKD incidence. Women have lower SUA levels than men because estrogen stimulates urinary urate excretion [12,13]. Hence, SUA levels and CKD incidence may be different between men and women.

Uric acid, a purine metabolism product, is reabsorbed and excreted in the renal proximal tubule after being filtered. Patients with CKD have decreased uric acid urinary excretion and elevated SUA levels [14]. While the inclusion of participants with eGFR close to 60 mL/min/1.73 m2 in the evaluation of the association between SUA levels and CKD incidence could lead to reverse causality, all previous studies included these individuals and only adjusted the results for baseline eGFR levels [[4], [5], [6], [7], [8], [9]].

We, therefore, examined the association between SUA levels and CKD incidence in middle-aged adults stratified by sex, based on a longitudinal analysis with multiple measurements of serum creatinine (SCr) acquired from a large-scale health checkup of a general Asian population. Then, we excluded participants with eGFR <70 mL/min/1.73 m2 due to their extremely high risk of CKD incidence [15]. Furthermore, we also assessed the association between low SUA levels and elevated risk of CKD incidence since this piece of information in middle-aged Asian individuals had been scarce [8,9].

Section snippets

Data source

Data for this retrospective cohort study were retrieved from the commercially available JMDC Inc. (Tokyo, Japan) administrative claims database. The database includes annual health checkup data from Japanese employees and their employees <75 years old, who are enrolled in health insurance plans offered by large companies [[15], [16], [17]]. Individuals ≥75 years old are not included in this database because they are covered by the public health insurance system (the medical care system for the

Baseline characteristics

The mean participant age was 44.1 years, and 29.6% of the participants were women. The mean SUA level was 5.9 mg/dL in men and 4.1 mg/dL in women. The number of participants with SUA levels ≥9.0 mg/dL was 810 (0.83%) in men and 6 (0.015%) in women.

Table 1 shows the participants' characteristics based on SUA levels in men and women. The proportion of dyslipidemia and the mean age of participants was associated positively and inversely, respectively, with men's SUA levels. The prevalence of

Discussion

This longitudinal study demonstrated that the risk of CKD incidence or proteinuria increased in individuals with SUA <4.0 and ≥ 10.0 mg/dL in men, and <4.0 and ≥ 7.0 mg/dL in women, compared to those with SUA 4.0–4.9 mg/dL, after adjustment for various covariates (Fig. 2, Fig. 3 and Supplementary Table S7). The present study also indicated that both low and high SUA levels could be associated with the risk of CKD incidence in Asian middle-aged men and women.

We indicated for the first time the

Financial support

This study was supported by Grants for Scientific Research (17K15853, 17K19930, 20K08612 and 21K10478) from the Ministry of Education, Culture, Sports, Science, and Technology, Japan; academic contributions from Pfizer Japan Inc., Japan; scholarship donations from Chugai Pharmaceutical Co., Ltd., Japan, and Daiichi Sankyo Co., Ltd., Japan; research supports from Astellas Pharma Inc., Japan, Takeda Pharmaceutical Co., Ltd., Japan, and Bayer Yakuhin Co., Ltd., Japan; the Health Care Science

CRediT authorship contribution statement

Shingo Nakayama: Conceptualization, Methodology, Formal analysis, Validation, Writing – original draft, Visualization. Michihiro Satoh: Conceptualization, Methodology, Resources, Data curation, Writing – review & editing, Supervision, Project administration, Funding acquisition. Yukako Tatsumi: Conceptualization, Methodology, Formal analysis, Writing – review & editing. Takahisa Murakami: Methodology, Writing – review & editing. Tomoko Muroya: Methodology, Writing – review & editing. Takuo

Declaration of competing interest

T.O. and H.M. concurrently held the position of director of the Tohoku Institute for Management of Blood Pressure, which was supported by Omron Healthcare Co., Ltd. The Division of Public Health, Hygiene and Epidemiology, Faculty of Medicine, Tohoku Medical and Pharmaceutical University received scholarship donations for education from Baxter Co., Ltd., and Otsuka Pharmaceutical Co., Ltd. The Division of Nephrology and Endocrinology, Faculty of Medicine, Tohoku Medical and Pharmaceutical

Acknowledgements

We are grateful to all the staff at JMDC Inc.

References (31)

  • K. Takae et al.

    Serum uric acid as a risk factor for chronic kidney disease in a Japanese community- the Hisayama study

    Circ. J.

    (2016)
  • P. Zhu et al.

    Serum uric acid is associated with incident chronic kidney disease in middle-aged populations: a meta-analysis of 15 cohort studies

    PloS One

    (2014)
  • S. Wang et al.

    Uric acid and incident chronic kidney disease in a large health check-up population in Taiwan

    Nephrology

    (2011)
  • K.H. Mun et al.

    Effect of uric acid on the development of chronic kidney disease: the Korean multi-rural communities cohort study

    J Prev Med Public Health

    (2018)
  • K. Mori et al.

    U-shaped relationship between serum uric acid level and decline in renal function during a 10-year period in female subjects: BOREAS-CKD2

    Hypertens. Res.

    (2021)
  • View full text